Literature DB >> 29132792

[Neuromeningeal cryptococcosis in patients infected with HIV at Agadir regional hospital, (Souss-Massa, Morocco)].

S Chadli1, M Aghrouch2, N Taqarort3, M Malmoussi4, Z Ouagari4, F Moustaoui2, M Bourouache5, S Oulkheir6.   

Abstract

INTRODUCTION: Neuromeningeal cryptococcosis (NMC) is a severe and fatal opportunistic infection. Lethality is frequent in the absence of treatment, especially in the presence of HIV co-infection.
OBJECTIVE: To determine the prevalence, epidemiological, clinical, biological and therapeutic aspects as well as the evolution of NMC for patients infected with HIV. PATIENTS AND METHODS: This is a retrospective study of 40 cases of neuromeningeal cryptococcosis diagnosed in HIV-infected patients. Data are collected for 7 years (from January 2010 to December 2016) in the registers of the parasitology laboratory and the infectious diseases department at the regional hospital center in Agadir.
RESULTS: A reduction in the prevalence of neuromeningeal cryptococcosis in HIV-infected patients was noted from 2010 to 2016 (3.66% to 0.83%). The overall prevalence of NMC was 1.53%. The mean age was 37±10 years old, with 90% of patients aged less than 45 years. The main clinical symptomatology was headache (75%). The main cytochemical abnormalities of cerebrospinal fluid analysis were hyperproteinorachy (60%), hypoglycorachy (63%) and lymphocytosis (50%). The mean CD4 cell count was 47/mm3. Patients were initially treated with amphotericin B, relayed with fluconazole. The overall lethality was 35%.
CONCLUSION: Neuromeningeal cryptococcosis is a serious opportunistic infection in patients HIV-infected, and the lethality rate remains unacceptable. Fighting NMC in HIV+ patients requires early diagnosis, increased access to antiretrovirals, rapid introduction of appropriate treatment and the prescription of effective systemic antifungals.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Agadir; Amphotericin B; Amphotéricine B; Antiretroviral drugs; Cryptococcose neuroméningée; Fluconazole; HIV/AIDS; Neuromeningeal cryptococcosis; Trithérapie HAART; VIH/sida

Year:  2017        PMID: 29132792     DOI: 10.1016/j.mycmed.2017.10.006

Source DB:  PubMed          Journal:  J Mycol Med        ISSN: 1156-5233            Impact factor:   2.391


  4 in total

1.  Occurrence and removal of intestinal parasites in two wastewater treatment plants in the south of Morocco.

Authors:  M Bourouache; R Mimouni; A Ait Alla; F Hamadi; A El Boulani; B Bihadassen; A Laktib; F Moustaoui; M Aghrouch
Journal:  J Environ Health Sci Eng       Date:  2021-06-30

2.  Clinical epidemiology and high genetic diversity amongst Cryptococcus spp. isolates infecting people living with HIV in Kinshasa, Democratic Republic of Congo.

Authors:  Bive Zono Bive; Rosalie Sacheli; Hippolyte Situakibanza Nani-Tuma; Pius Kabututu Zakayi; Alex Ka; Marcel Mbula Mambimbi; Gaultier Muendele; Raphael Boreux; Nicole Landu; Celestin Nzanzu Mudogo; Pierre-Robert M'Buze; Michel Moutschen; Wieland Meyer; Georges Mvumbi Lelo; Marie-Pierre Hayette
Journal:  PLoS One       Date:  2022-05-19       Impact factor: 3.752

3.  The prevalence of syphilis in HIV-seropositive patients: a retrospective study at the regional hospital in Agadir, Morocco.

Authors:  Mohamed Bourouache; Rachida Mimouni; Mohamed Nejmeddine; Smail Chadli; Fatima Benlmeliani; Jamila Sardi; Mourad Malmoussi; Zineb Ouagari; Maryam El Basbassi; Mohamed Aghrouch
Journal:  Pan Afr Med J       Date:  2019-07-25

4.  Neuromeningeal cryptoccocosis revealing IgA-λ multiple myeloma.

Authors:  Latifa Mtibaa; Imen Beji; Manel Ayoub; Nawel Baccouchi; Souha Hannechi; Zied Aouni; Rym Abid; Chakib Mazigh; Riadh Battikh; Boutheina Jemli
Journal:  Med Mycol Case Rep       Date:  2021-02-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.